Trading Members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement among Sanofi India Limited and Sanofi Consumer Healthcare India Limited as approved by the Hon'ble National Company Law Tribunal, Mumbai Bench, SANOFI INDIA LIMITED has fixed Record Date for the purpose of determining the entitlement of the shareholders of the Company, as per details given below: -
|
COMPANY NAME
CODE
|
RECORD DATE
|
PURPOSE
|
EX-ENTITLEMENT FROM
DATE &
SETT. NO.
|
|
SANOFI INDIA LIMITED
(500674)
|
13/06/2024
|
As per Scheme of Arrangement sanctioned by the Hon'ble National Company Law Tribunal, Mumbai Bench, inter alia, between, SANOFI INDIA LIMITED, (Demerged Company) and Sanofi Consumer Healthcare India Limited (Resulting Company) and their Respective Shareholders and Creditors;
The Scheme of Arrangement proposes the Demerger of Consumer Healthcare business of the Company to Sanofi Consumer Healthcare India Limited (Resulting Company) ;
Upon the Scheme coming into effect and In consideration of the Demerger of the Consumer Healthcare business of the Company to Sanofi Consumer Healthcare India Limited (Resulting Company);
Sanofi Consumer Healthcare India Limited (Resulting Company) shall issue and allot Equity Shares to the Shareholders of Sanofi India Limited in the following proportion:-
“Each Member of Sanofi India Limited holding One (1) Fully Paid-up Equity Share in Sanofi India Limited as on the Record Date shall in respect of every One (1) Fully Paid-Up Equity Share of Rs.10/- each held in Sanofi India Limited be entitled to receive One (1) Fully Paid-Up Equity Share of Rs.10/- each of Sanofi Consumer Healthcare India Limited
|
13/06/2024
DR-652/2024-2025
|
Note:
(1) Pursuant to SEBI Circular No. SEBI/Cir/ISD/1/2010 dated November 2, 2010, Trading members are hereby informed that the trading in the Equity Shares of the aforesaid Company shall be transferred from ‘A’ group to ‘T’ Froup w.e.f. 13th June, 2024, and
(2) Pursuant to SEBI Circular No. CIR/MRD/DP/01/2012 dated January 20, 2012, the aforesaid scrip shall be a part of Call Auction in Pre-open Session (Special Pre- open Session (SPOS)) on 13th June, 2024. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session.
Subject to compliance with requisite formalities, the Equity Shares of the Resulting Company i.e. Sanofi Consumer Healthcare India Limited will be listed on BSE Limited.
Marian Dsouza
Senior Manager –Listing Operations (CRD)
June 11, 2024 |